sabbiotherapeutics.com (SABS) Company Sales Volume
SAB Biotherapeutics is optimizing plasma delivery for therapy, enhancing supply chain profitability. Innovations in antibody development to combat diabetes are strengthening the brand's scientific standing. The company's sales history on this GURU.Markets platform chart reflects these successes, with the value recorded at 0.00. Stability is maintained through strategic partnerships with external genetic laboratories.
Comprehensive metric breakdowns and analytics for SAB Biotherapeutics, Inc. (SABS)
- price and consensus price forecast:
- market capitalization details:
- issuer book value statistics:
- debt and solvency information:
Total Debt to Capital SAB Biotherapeutics|SABS - Long-Term Debt to Capital|Short-Term Debt to Equity SAB Biotherapeutics Inc.|SABS - Company Total Debt|Debt to Net Assets Ratio SAB Biotherapeutics, Inc.|SABS - Company Long-Term Debts|Company Short-Term Debt SAB Biotherapeutics|Interim Coverage Ratio sabbiotherapeutics.com
- business earnings and investment ratios data:
SABS - Company Net Income|Expected Net Profit SAB Biotherapeutics|SABS - Price to Earnings Ratio|Market Cap to Future Earnings Ratio sabbiotherapeutics.com|SABS - PEG Multiple|Business Value to Operating Income Before Depreciation SAB Biotherapeutics, Inc.|SABS - Operating profit EBITDA|Net earnings per one share for the last twelve months SAB Biotherapeutics|SABS - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months sabbiotherapeutics.com|SABS - Earnings growth in current year|Earnings growth forecast for next year SAB Biotherapeutics
- sales volume and revenue indicators:
General company analysis:SAB Biotherapeutics Inc - SABS
Fundamental revenue analysis minimizes risks when assessing the viability of biotech startups. This is critical for SAB Biotherapeutics (SABS), as competing for grants against industry behemoths requires proof of the commercial demand for antibodies. This metric tracks daily cash inflows from product sales, reflecting the volatility of the company's sales dynamics. Steady growth in this flow confirms capital resilience in the face of industry shocks.
Key competitors
Revenue and Sales Volume argenx BVBA|Company Revenue BioNTech SE (BNTX)|Abivax SA - Company Sales Volume|Revenue and Sales Volume ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Company Total Revenue|IMVT - Company Revenue|Company Gross Revenue Kiniksa Corp KNSA|GRFS: Revenue and Sales Volume|adaptivebiotech.com (ADPT) - Revenue and Sales Volume|CLDX (Celldex Therapeutics, Inc.) - Revenue and Sales Volume|Company Revenue AUPH|Company Sales BCRX (BioCryst Pharmaceuticals Inc)|VERA (Vera Corp) - Company Sales Revenue|Revenue and Sales Volume DNTH (Dianthus Therapeutics)|pharvaris.com - Company Revenue|AbCellera - Revenue and Sales Volume|Company Gross Revenue Tourmaline Bio Inc TRML|Intrexon (PGEN) - Company Revenue|Company Total Revenue Pharming Corp (PHAR)|Company Sales NKTR|UPB (upstreambio.com) - Company Total Sales|Revenue and Sales Volume ZBIO|IMNM (Immunome Inc) - Company Sales Revenue|Revenue and Sales Volume GOSS (Gossamer Corp)|KalVista Corp (KALV) - Company Total Revenue|SEPN - Company Revenue|Company Sales Revenue PVLA (pieris.com)|SVRA: Revenue and Sales Volume|Rigel Pharma (RIGL) - Revenue and Sales Volume|Company Revenue AnaptysBio Corp|Astria Corp - Company Annual Revenue|Revenue and Sales Volume ENGN|RAPT - Company Total Revenue|Aerovate Therapeutics - Company Sales|Revenue and Sales Volume Aclaris Therapeutics Inc. ACRS|KYTX: Company Sales|Tiziana Life Sciences, Ltd. - Company Total Sales|CABA: Revenue and Sales Volume|VTYX - Company Gross Revenue|THTX (Theratechnologies) - Revenue and Sales Volume|Company Sales Avalo Therapeutics, Inc. (AVTX)|Company Revenue Eledon (ELDN)|Company Gross Revenue Agenus, Inc|Company Revenue Climb Bio Inc CLYM|Company Gross Revenue zurabio.com (ZURA)|aTyr Pharma - Revenue and Sales Volume|ADAG - Revenue and Sales Volume|IMA: Revenue and Sales Volume|STTK (Shattuck Labs) - Company Revenue|Company Revenue Equillium Inc|Connect Pharma (CNTB) - Company Gross Revenue|Company Revenue Immunic, Inc. (IMUX)|ATRA: Company Annual Revenue|Revenue and Sales Volume IFRX (InflaRx)|Company Sales Revenue XFOR|Adicet - Revenue and Sales Volume|CELU - Revenue and Sales Volume|INmune Bio (INMB) - Company Revenue|Barinthus Biotherapeutics PLC - Company Sales Revenue|Company Revenue Kezar Life Sciences, Inc|Company Sales Akari Therapeutics, Plc (AKTX)|Revenue and Sales Volume ENLV|Revenue and Sales Volume q32bio.com (QTTB)|GeoVax - Company Sales|Company Sales Revenue EDSA|iBio Corp - Revenue and Sales Volume|Company Gross Revenue Carisma Therapeutics CARM|XTL Biopharmaceuticals (XTLB) - Company Revenue|Company Sales Bolt Biotherapeutics, Inc.|Company Revenue HCW Biologics, Inc.|Company Sales Aptevo (APVO)|Company Sales AIM (AIM ImmunoTech)|Revenue and Sales Volume aditxt.com (ADTX)|Company Revenue GRI Bio, Inc. GRI|XRTX: Company Sales Volume|Vyome Holdings - Revenue and Sales Volume|Company Total Revenue Revelation Biosciences Inc|Indaptus (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica Inc) - Revenue and Sales Volume|Revenue and Sales Volume Affimed Therapeutics|Revenue and Sales Volume ALLK|Company Revenue HOOK (hookipapharma.com)|IGM Biosciences - Company Sales|Company Sales Revenue ITOS|Ocean Biomedical, Inc. - Revenue and Sales Volume|TCBP: Company Revenue|THRD: Revenue and Sales Volume
